Role of CC chemokine receptor 1 and two of its ligands in human dengue infection. Three approaches under the Cuban situation

Microbes and Infection

Volumn 16, Issue 1, 2014, Pages 40-50

  Sierra, Beatriz ^a   Perez, Ana B ^a   Garcia, Gissel ^a   Aguirre, Eglys ^a   Alvarez, Mayling ^a   Gonzalez, Daniel ^a   Guzman, Maria G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Chemokines; Dengue; Gene expression; Immunopathogenesis

Indexed keywords

CHEMOKINE RECEPTOR CCR1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES;

ADULT; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; MALE; MEMORY; MIDDLE AGED; PRIMARY INFECTION; PRIORITY JOURNAL; SECONDARY INFECTION; SPLEEN; YOUNG ADULT;

CHEMOKINES; DENGUE; GENE EXPRESSION; IMMUNOPATHOGENESIS;

ADULT; BRAIN; CHEMOKINE CCL3; CHEMOKINE CCL5; CUBA; DENGUE; DENGUE VIRUS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; LIGANDS; MALE; MIDDLE AGED; RECEPTORS, CCR1; RNA, MESSENGER; SPLEEN; YOUNG ADULT;

EID: 84892477231     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.10.011     Document Type: Article

References (49)

1. Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., Hunsperger E., Kroeger A., Margolis H.S., Martinez E., Nathan M.B., Pelegrino J.L., Simmons C., Yoksan S., Peeling R.W. Dengue: a continuing global threat. Nat. Rev. Microbiol. 2010, 8:S7-S16.
2. Halstead S.B. Dengue. Curr. Opin. Infect. Dis. 2002, 15:471-476.
3. Rothman A.L. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 2011, 11:532-543.
4. Guzman M.G., Alvarez M., Halstead S.B. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch. Virol. 2013, 158:1445-1459.
5. Mantovani A. Chemokines. Introduction and overview. Chem. Immunol. 1999, 72:1-6.
6. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000, 18:217-242.
7. Lee Y.R., Liu M.T., Lei H.Y., Liu C.C., Wu J.M., Tung Y.C., Lin Y.S., Yeh T.M., Chen S.H., Liu H.S. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J. Gen. Virol. 2006, 87:3623-3630.
8. Chen Y.C., Wang S.Y. Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J. Virol. 2002, 76:9877-9887.
9. Ho L.J., Wang J.J., Shaio M.F., Kao C.L., Chang D.M., Han S.W., Lai J.H. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 2001, 166:1499-1506.
10. Avirutnan P., Malasit P., Seliger B., Bhakdi S., Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 1998, 161:6338-6346.
11. Bozza F.A., Cruz O.G., Zagne S.M., Azeredo E.L., Nogueira R.M., Assis E.F., Bozza P.T., Kubelka C.F. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect. Dis. 2008, 8.
12. Spain-Santana T.A., Marglin S., Ennis F.A., Rothman A.L. MIP-1 alpha and MIP-1 beta induction by dengue virus. J. Med. Virol. 2001, 65:324-330.
13. Guabiraba R., Marques R.E., Besnard A.G., Fagundes C.T., Souza D.G., Ryffel B., Teixeira M.M. Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice. PLoS One 2010, 5:e15680.
14. Guzman M.G., Kouri G., Valdes L., Bravo J., Vazquez S., Halstead S.B. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev. Panam. Salud Publica 2002, 11:223-227.
15. Pelaez O., Guzman M.G., Kouri G., Perez R., San Martin J.L., Vazquez S., Rosario D., Mora R., Quintana I., Bisset J., Cancio R., Masa A.M., Castro O., Gonzalez D., Avila L.C., Rodriguez R., Alvarez M., Pelegrino J.L., Bernardo L., Prado I. Dengue 3 epidemic, Havana, 2001. Emerg. Infect. Dis. 2004, 10:719-722.
16. Vazquez S., Bravo J.R., Perez A.B., Guzman M.G. Inhibition ELISA, utility for classifying a case of dengue. Rev. Cubana Med. Trop. 1997, 49:108-112.
17. Morens D.M., Halstead S.B., Repik P.M., Putvatana R., Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 1985, 22:250-254.
18. Libel M. Brote de dengue en Cuba. Enfermedades infecciosas emergentes y reemergentes. Región de las Américas 2006, OPS, Habana.
19. World Health Organization Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control 1997, WHO, Geneve.
20. Vazquez S., Perez A.B., Ruiz D., Rodriguez R., Pupo M., Calzada N., Gonzalez L., Gonzalez D., Castro O., Serrano T., Guzman M.G. Serological markers during dengue 3 primary and secondary infections. J. Clin. Virol. 2005, 33:132-137.
21. Rodriguez-Roche R., Alvarez M., Guzman M.G., Morier L., Kouri G. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. J. Clin. Microbiol. 2000, 38:3508-3510.
22. Rosario D., Alvarez M., Diaz J., Contreras R., Rodriguez R., Vazquez S., Guzman M.G. Polymerase chain reaction for rapid detection and serotyping of dengue virus in clinical samples. Rev. Panam Salud Publica 1998, 4:1-5.
23. Guzman M.G., Alvarez M., Rodriguez R., Rosario D., Vazquez S., Vald s.L., Cabrera M.V., Kouri G., et al. Fatal dengue hemorrhagic fever in Cuba, 1997. Int. J. Infect. Dis. 1999, 3:130-135.
24. Lukacs N.W., Hogaboam C., Campbell E., Kunkel S. Chemokines: function, regulation and alteration of inflammatory responses. Chem. Immunol. 1999, 72:102-120.
25. Sierra B., Perez A.B., Vogt K., Garcia G., Schmolke K., Aguirre E., Alvarez M., Volk H.D., Guzman M.G. MCP-1 and MIP-1alpha expression in a model resembling early immune response to dengue. Cytokine 2010, 52:175-183.
26. Pease J.E., Horuk R. CCR1 antagonists in clinical development. Expert Opin. Investig. Drugs 2005, 14:785-796.
27. L.M. de-Oliveira-Pinto, C.F. Marinho, T.F. Povoa, E.L. de Azeredo, L.A. de Souza, L.D. Barbosa, A.R. Motta-Castro, A.M. Alves, C.A. Ávila, L.J. de Souza, R.V. da Cunha, P.V. Damasco, M.V. Paes, C.F. Kubelka, Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever, PLoS One, 7, e38527.
28. Pérez A.B., García G., Sierra B., Alvarez M., Vázquez S., Cabrera M.V., Rodríguez R., Rosario D., Martínez E., Denny T., Guzmán M.G. IL-10 levels in dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J. Med. Virol. 2004, 73:230-234.
29. Guzman M.G., Kouri G., Vazquez S., Rosario D., Bravo J.R., Valdez L. DHF epidemics in Cuba, 1981 and 1997: some interesting observations. Dengue Bull. 1999, 23:39-43.
30. Alvarez M., Rodriguez-Roche R., Bernardo L., Vazquez S., Morier L., Gonzalez D., Castro O., Kouri G., Halstead S.B., Guzman M.G. Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am. J. Trop. Med. Hyg. 2006, 75:1113-1117.
31. Sierra B., Perez A.B., Alvarez M., Garcia G., Vogt K., Aguirre E., Schmolke K., Volk H.D., Guzman M.G. Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus. Am. J. Trop. Med. Hyg. 2012, 87:538-547.
32. Alvarez M., Pavón-Oro A., Vázquez S., Morier L., Alvarez A.M., Guzmán M.G. Secuencias de infección viral asociadas a la fiebre del dengue durante la epidemia de dengue 3 en la ciudad de La Habana, 2001-2002. Rev. Cubana Med. Trop. 2008, 60:26-30.
33. Navarro-Sanchez E., Despres P., Cedillo-Barron L. Innate immune responses to dengue virus. Arch. Med. Res. 2005, 36:425-435.
34. Butthep P., Chunhakan S., Yoksan S., Tangnararatchakit K., Chuansumrit A. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever. Pediatr. Infect Dis. J. 2012, 31:e232-e238.
35. Locati M., Murphy P.M. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 1999, 50:425-440.
36. Ribeiro S., Horuk R. The clinical potential of chemokine receptor antagonists. Pharmacol. Ther. 2005, 107:44-58.
37. Levy J.A. The unexpected pleiotropic activities of RANTES. J. Immunol. 2009, 182:3945-3946.
38. Blanchet X., Langer M., Weber C., Koenen R.R., von Hundelshausen P. Touch of chemokines. Front. Immunol. July 12, 2012, 3:175.
39. Halstead S.B., Rojanasuphot S., Sangkawibha N. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg. 1983, 32:154-156.
40. Weber C., Weber K.S.C., Klier C., Gu S., Wank R., Horuk R., Nelson P.J. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and TH1-like/CD45RO+ T cells. Blood 2001, 97:1144-1146.
41. Kohlmeier J.E., Miller S.C., Smith J., Lu B., Gerard C., Cookenham T., Roberts A.D., Woodland D.L., et al. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 2008, 29:101-113.
42. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1alpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.
43. Saito T., Deskin R.W., Casola A., Haeberle H., Olszewska B., Ernst P.B., Alam R., Ogra P.L., Garofalo R. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J. Infect. Dis. 1997, 175:497-504.
44. Glass W.G., Lim J.K., Cholera R., Pletnev A.G., Gao J.L., et al. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005, 202:1087-1098.
45. Lim J.K., McDermott D.H., Lisco A., Foster G.A., Krysztof D., et al. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J. Infect. Dis. 2010, 201:178-185.
46. Sam S.S., Omar S.F., Teoh B.T., Abd-Jamil J., AbuBakar S. Review of dengue hemorrhagic fever fatal cases seen among adults: a retrospective study. PLoS Neglected Trop. Dis. 2013, 7:e2194.
47. Adler M.W., Rogers T.J. Are chemokines the third major system in the brain?. J. Leukoc. Biol. 2005, 78:1204-1209.
48. Carod-Artal F.J., Wichmann O., Farrar J., Gascón J. Neurological complications of dengue virus infection. Lancet Neurol. 2013, 12:906-919.
49. Thisyakorn U., Thisyakorn C., Limpitikul W., Nisalak A. Dengue infection with central nervous system manifestations. Southeast Asian J. Trop. Med. Public Health 1999, 30:504-506.